|
|
Volumn 176, Issue , 2007, Pages 189-199
|
|
Antiangiogenesis, anti-VEGF(R) and outlook.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
ANTINEOPLASTIC AGENT;
ISOPROTEIN;
VASCULOTROPIN A;
VASCULOTROPIN RECEPTOR;
CLASSIFICATION;
CLINICAL TRIAL;
DRUG ANTAGONISM;
HUMAN;
METABOLISM;
NEOVASCULARIZATION (PATHOLOGY);
REVIEW;
ANGIOGENESIS INHIBITORS;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS;
HUMANS;
NEOVASCULARIZATION, PATHOLOGIC;
PROTEIN ISOFORMS;
RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
MLCS;
MLOWN;
|
|
EID: 34547152236
PISSN: 00800015
EISSN: None
Source Type: Journal
DOI: 10.1007/978-3-540-46091-6_16 Document Type: Review |
|
Times cited : (22)
|
|
References (38)
|
